Specific 14-3-3 isoform detection and immunolocalization in prion diseases

被引:31
作者
Baxter, HC
Fraser, JR
Liu, WG
Forster, JL
Clokie, S
Steinacker, P
Otto, M
Bahn, E
Wiltfang, J
Aitken, A
机构
[1] Univ Edinburgh, Dept Biomed Sci, Edinburgh EH8 9XD, Midlothian, Scotland
[2] Inst Anim Hlth, Neuropathogenesis Unit, Edinburgh EH9 3JF, Midlothian, Scotland
[3] Univ Gottingen, Dept Neurol, D-37075 Gottingen, Germany
[4] Univ Gottingen, Dept Neuropathol, D-37075 Gottingen, Germany
[5] Univ Gottingen, Dept Psychiat, D-37075 Gottingen, Germany
关键词
CSF; ELISA; immunocytochemistry; neurodegeneration;
D O I
10.1042/bst0300387
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
14-3-3 proteins are involved in signalling processes in neuronal cells. Using isoform-specific antibodies we have examined the variation in 14-3-3 isoform neurolocation in normal and scrapie-infected murine brain and show that in defined areas of the brain there are significant changes associated with the pathology of the disease process. The appearance of 14-3-3 proteins in the cerebrospinal fluid (CSF) is a consequence of neuronal disease and the detection of specific isoforms of the 14-3-3 proteins in the CSF is characteristic of some neurodegenerative diseases. In this study, monitoring specifically for the gamma 14-3-3 isoform in the CSF by both Western-blot analysis and ELISA we can show a level of correlation between the assays.
引用
收藏
页码:387 / 391
页数:5
相关论文
共 28 条
  • [11] 2-A
  • [12] Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins
    Layfield, R
    Fergusson, J
    Aitken, A
    Lowe, J
    Landon, M
    Mayer, RJ
    [J]. NEUROSCIENCE LETTERS, 1996, 209 (01) : 57 - 60
  • [13] The assay development of a molecular marker for transmissible spongiform encephalopathies
    Lee, KH
    Harrington, MG
    [J]. ELECTROPHORESIS, 1997, 18 (3-4) : 502 - 506
  • [14] MARTIN H, 1994, J NEUROCHEM, V63, P2259
  • [15] Interaction of 14-3-3 with signaling proteins is mediated by the recognition of phosphoserine
    Muslin, AJ
    Tanner, JW
    Allen, PM
    Shaw, AS
    [J]. CELL, 1996, 84 (06) : 889 - 897
  • [16] S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Otto, M
    Stein, H
    Szudra, A
    Zerr, I
    Bodemer, M
    Gefeller, O
    Poser, S
    Kretzschmar, HA
    Mader, M
    Weber, T
    [J]. JOURNAL OF NEUROLOGY, 1997, 244 (09) : 566 - 570
  • [17] Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Otto, M
    Wiltfang, J
    Tumani, H
    Zerr, I
    Lantsch, M
    Kornhuber, J
    Weber, T
    Kretzschmar, HA
    Poser, S
    [J]. NEUROSCIENCE LETTERS, 1997, 225 (03) : 210 - 212
  • [18] NOVEL PROTEINACEOUS INFECTIOUS PARTICLES CAUSE SCRAPIE
    PRUSINER, SB
    [J]. SCIENCE, 1982, 216 (4542) : 136 - 144
  • [19] The 14-3-3 protein detectable in the cerebrospinal fluid of patients with prion-unrelated neurological diseases is expressed constitutively in neurons and glial cells in culture
    Satoh, J
    Kurohara, K
    Yukitake, M
    Kuroda, Y
    [J]. EUROPEAN NEUROLOGY, 1999, 41 (04) : 216 - 225
  • [20] Increased levels of ε and γ isoforms of 14-3-3 proteins in cerebrospinal fluid in patients with Creutzfeldt-Jakob disease
    Takahashi, H
    Iwata, T
    Kitagawa, Y
    Takahashi, RH
    Sato, Y
    Wakabayashi, H
    Takashima, M
    Kido, H
    Nagashima, K
    Kenney, K
    Gibbs, CJ
    Kurata, T
    [J]. CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1999, 6 (06) : 983 - 985